Psychedelics in Psychiatry
- 1st Edition, Volume 181 - June 16, 2025
- Imprint: Academic Press
- Editors: David J. Nutt, Hannah Thurgur
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 3 4 3 8 5 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 4 3 8 6 - 5
Psychedelics in Psychiatry, Volume 181, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presen… Read more
Purchase options
Psychedelics in Psychiatry, Volume 181, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Chapters in this new volume include History of psychedelic drug science and molecular pharmacology, Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents, Anti-inflammatory activity, Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents, Clinical pharmacology, Human neuroimaging fMRI, and more.
Other chapters in this new release include Effects of psychedelics on human oscillatory brain activity, Molecular neuroimaging of psychedelic drug effects, Neurobiology of sub-psychedelic doses, Depression and related disorders, Addictions, Trauma disorders, Neurological disorders, and Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy.
Other chapters in this new release include Effects of psychedelics on human oscillatory brain activity, Molecular neuroimaging of psychedelic drug effects, Neurobiology of sub-psychedelic doses, Depression and related disorders, Addictions, Trauma disorders, Neurological disorders, and Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy.
- Provides the authority and expertise of leading contributors from an international board of authors
- Presents the latest release in the International Review on Neurobiology series
- Includes updated information on Psychedelics in Psychiatry
Undergraduates, graduates, academics, and researchers in the field of Neurology
Section 1
1. History of psychedelic drug science and molecular pharmacology
2. Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents
3. Anti-inflammatory activity
4. Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents
5. Clinical pharmacology
6. Human neuroimaging fMRI
7. Effects of psychedelics on human oscillatory brain activity
8. Molecular neuroimaging of psychedelic drug effects
9. Neurobiology of sub-psychedelic doses
Section 2
10. Depression and related disorders
11. Addictions
12. Trauma disorders
13. Neurological disorders
Section 3
14. Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy
1. History of psychedelic drug science and molecular pharmacology
2. Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents
3. Anti-inflammatory activity
4. Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents
5. Clinical pharmacology
6. Human neuroimaging fMRI
7. Effects of psychedelics on human oscillatory brain activity
8. Molecular neuroimaging of psychedelic drug effects
9. Neurobiology of sub-psychedelic doses
Section 2
10. Depression and related disorders
11. Addictions
12. Trauma disorders
13. Neurological disorders
Section 3
14. Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy
- Edition: 1
- Volume: 181
- Published: June 16, 2025
- Imprint: Academic Press
- Language: English
DN
David J. Nutt
Affiliations and expertise
Psychopharmacology Unit, University of Bristol, UK
Professor of PsychopharmacologyRead Psychedelics in Psychiatry on ScienceDirect